Hjem › Tripelnegativ brystkreft › California › San Diego
Kliniske studier for Tripelnegativ brystkreft i San Diego, CA
13 studier for Tripelnegativ brystkreft søker deltakere på steder i og rundt San Diego (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekruttererFase 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mi unna
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruttererFase 1/2
- University of San Diego Moores Cancer Center, La Jolla · 11 mi unna
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekruttererObservasjonsstudie
- University of California San Diego, La Jolla · 11 mi unna
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
RekruttererFase 3
- Scripps Cancer Center ( Site 0052), La Jolla · 11 mi unna
Intratumoral N17350 in Advanced Solid Tumors
RekruttererFase 1/2
- Scripps Clinic Torrey Pines - La Jolla, San Diego
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RekruttererFase 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mi unna
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
RekruttererFase 1
- UC San Diego Moores Cancer Center, La Jolla · 11 mi unna
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruttererFase 1/2
- University of California, San Diego; Moores Cancer Center, San Diego
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruttererFase 2
- University of California San Diego, La Jolla · 11 mi unna
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
RekruttererFase 1
- UCSD Moores Cancer Center, La Jolla · 11 mi unna
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
RekruttererFase 1/2
- UCSD Moores Cancer Center, La Jolla · 11 mi unna
A Beta-only IL-2 ImmunoTherapY Study
RekruttererFase 1/2
- Sharp Memorial Hospital, San Diego
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
RekruttererFase 1
- UC San Diego Moores Cancer Center, La Jolla · 11 mi unna
Tripelnegativ brystkreft-studier i andre byer
- Houston, TX42 studier
- New York City, NY31 studier
- Nashville, TN28 studier
- Los Angeles, CA27 studier
- Boston, MA26 studier
- San Antonio, TX23 studier
- St. Louis, MO21 studier
- Arlington, VA20 studier
- Atlanta, GA20 studier
- Dallas, TX18 studier
- Chicago, IL16 studier
- Columbus, OH16 studier
Andre studier i San Diego
- Ikke-småcellet lungekreft48 studier
- Brystkreft41 studier
- Kreft (alle typer)32 studier
- Prostatakreft31 studier
- Metastatisk kreft30 studier
- Kolorektal kreft25 studier
- Eggstokkreft24 studier
- Pankreaskreft24 studier
- Lungekreft23 studier
- Fedme23 studier
- Hjertesvikt23 studier
- Depresjon21 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.